EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations
This EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of May 1, 2023 by and between Cerevel Therapeutics, LLC (the “Company”) and Ronald Renaud (the “Executive”).
WAIVERWaiver • August 2nd, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations
This Waiver (this “Waiver”) is made and entered into as of April 27, 2023, by and among Cerevel Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and the undersigned investors (the “Investors”).
PERFORMANCE RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE CEREVEL THERAPEUTICS HOLDINGS, INC.Performance Restricted Stock Unit Award Agreement • August 2nd, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations
Pursuant to the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan as amended through the date hereof (the “Plan”), Cerevel Therapeutics Holdings, Inc. (the “Company”) hereby grants an award (an “Award”) of the target number of Restricted Stock Units listed above (the “Target Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.0001 per share (the “Stock”) of the Company.
